Robotics in Interventional Radiology: Review of Current and Future Applications

被引：0

作者：

Lanza, Carolina ^{[1
]}

Carriero, Serena ^{[1
]}

Buijs, Elvira Francisca Maria ^{[1
]}

Mortellaro, Sveva ^{[1
]}

Pizzi, Caterina ^{[1
]}

Sciacqua, Lucilla Violetta ^{[1
]}

Biondetti, Pierpaolo ^{[2
,3
]}

Angileri, Salvatore Alessio ^{[2
]}

Ianniello, Andrea Antonio ^{[4
]}

Ierardi, Anna Maria ^{[2
]}

Carrafiello, Gianpaolo ^{[2
,3
]}

机构：

[1] Univ Milan, Postgrad Sch Radiodiagnost, I-20122 Milan, Italy

[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[3] Univ Milan, Milan, Italy

[4] Osped L Sacco, Milan, Italy

来源：

TECHNOLOGY IN CANCER RESEARCH & TREATMENT | 2023年 / 22卷

关键词：

endovascular; interventional radiology; navigation oncology; percutaneous; robotics; robotic systems; HYPERPROGRESSIVE DISEASE; CANCER; IMMUNOTHERAPY; GUIDELINES; BLOCKADE; THERAPY; IMMUNE;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This review is a brief overview of the current status and the potential role of robotics in interventional radiology. Literature published in the last decades, with an emphasis on the last 5 years, was reviewed and the technical developments in robotics and navigational systems using CT-, MR- and US-image guidance were analyzed. Potential benefits and disadvantages of their current and future use were evaluated. The role of fusion imaging modalities and artificial intelligence was analyzed in both percutaneous and endovascular procedures. A few hundred articles describing results of single or several systems were included in our analysis.

引用

页数：15

共 29 条

[1] Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer [J].

Aoki, Masahiko ;

Shoji, Hirokazu ;

Nagashima, Kengo ;

Imazeki, Hiroshi ;

Miyamoto, Takahiro ;

Hirano, Hidekazu ;

Honma, Yoshitaka ;

Iwasa, Satoru ;

Okita, Natsuko ;

Takashima, Atsuo ;

Kato, Ken ;

Higuchi, Kazuhide ;

Boku, Narikazu .

ESMO OPEN, 2019, 4 (03)

[2] Hyperprogressive Disease: Main Features and Key Controversies [J].

Arasanz, Hugo ;

Zuazo, Miren ;

Bocanegra, Ana ;

Chocarro, Luisa ;

Blanco, Ester ;

Martinez, Maite ;

Morilla, Idoia ;

Fernandez, Gonzalo ;

Teijeira, Lucia ;

Morente, Pilar ;

Echaide, Miriam ;

Castro, Natalia ;

Fernandez, Leticia ;

Garnica, Maider ;

Ramos, Pablo ;

Escors, David ;

Kochan, Grazyna ;

Vera, Ruth .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (07)

[3] Novel patterns of response under immunotherapy [J].

Borcoman, E. ;

Kanjanapan, Y. ;

Champiat, S. ;

Kato, S. ;

Servois, V. ;

Kurzrock, R. ;

Goel, S. ;

Bedard, P. ;

Le Tourneau, C. .

ANNALS OF ONCOLOGY, 2019, 30 (03) :385-396

[4] Hyperprogressive Disease in Patients with Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors: The Role of 18F-FDG PET/CT [J].

Castello, Angelo ;

Rossi, Sabrina ;

Mazziotti, Emanuela ;

Toschi, Luca ;

Lopci, Egesta .

JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (06) :821-826

[5] Hyperprogressive disease: recognizing a novel pattern to improve patient management [J].

Champiat, Stephane ;

Ferrara, Roberto ;

Massard, Christophe ;

Besse, Benjamin ;

Marabelle, Aurelien ;

Soria, Jean-Charles ;

Ferte, Charles .

NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (12) :748-762

[6] Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1 [J].

Champiat, Stephane ;

Dercle, Laurent ;

Ammari, Samy ;

Massard, Christophe ;

Hollebecque, Antoine ;

Postel-Vinay, Sophie ;

Chaput, Nathalie ;

Eggermont, Alexander ;

Marabelle, Aurelien ;

Soria, Jean-Charles ;

Ferte, Charles .

CLINICAL CANCER RESEARCH, 2017, 23 (08) :1920-1928

[7]

Cortes J, 2020, LANCET, V396, P1817, DOI 10.1016/S0140-6736(20)32531-9

[8] Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy [J].

Ferrara, Roberto ;

Mezquita, Laura ;

Texier, Matthieu ;

Lahmar, Jihene ;

Audigier-Valette, Clarisse ;

Tessonnier, Laurent ;

Mazieres, Julien ;

Zalcman, Gerard ;

Brosseau, Solenn ;

Le Moulec, Sylvestre ;

Leroy, Laura ;

Duchemann, Boris ;

Lefebvre, Corentin ;

Veillon, Remi ;

Westeel, Virginie ;

Koscielny, Serge ;

Champiat, Stephane ;

Ferte, Charles ;

Planchard, David ;

Remon, Jordi ;

Boucher, Marie-Eve ;

Gazzah, Anas ;

Adam, Julien ;

Bria, Emilio ;

Tortora, Giampaolo ;

Soria, Jean-Charles ;

Besse, Benjamin ;

Caramella, Caroline .

JAMA ONCOLOGY, 2018, 4 (11) :1543-1552

[9] Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer [J].

Gandhi, L. ;

Rodriguez-Abreu, D. ;

Gadgeel, S. ;

Esteban, E. ;

Felip, E. ;

De Angelis, F. ;

Domine, M. ;

Clingan, P. ;

Hochmair, M. J. ;

Powell, S. F. ;

Cheng, S. Y. -S. ;

Bischoff, H. G. ;

Peled, N. ;

Grossi, F. ;

Jennens, R. R. ;

Reck, M. ;

Hui, R. ;

Garon, E. B. ;

Boyer, M. ;

Rubio-Viqueira, B. ;

Novello, S. ;

Kurata, T. ;

Gray, J. E. ;

Vida, J. ;

Wei, Z. ;

Yang, J. ;

Raftopoulos, H. ;

Pietanza, M. C. ;

Garassino, M. C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) :2078-2092

[10] Comparison of radiological criteria for hyperprogressive disease in response to immunotherapy [J].

Gomes da Morais, Ana Luiza ;

de Miguel, Maria ;

Miguel Cardenas, Jose ;

Calvo, Emiliano .

CANCER TREATMENT REVIEWS, 2020, 91

← 1 2 3 →